KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $983000.0.

  • Staar Surgical's Cash from Financing Activities fell 3913.31% to $983000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year decrease of 17442.35%. This contributed to the annual value of $5.7 million for FY2024, which is 2280.51% down from last year.
  • As of Q3 2025, Staar Surgical's Cash from Financing Activities stood at $983000.0, which was down 3913.31% from -$4.5 million recorded in Q2 2025.
  • Over the past 5 years, Staar Surgical's Cash from Financing Activities peaked at $20.2 million during Q1 2021, and registered a low of -$4.5 million during Q2 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was $1.1 million (2023), whereas its average is $2.7 million.
  • As far as peak fluctuations go, Staar Surgical's Cash from Financing Activities skyrocketed by 39801.62% in 2024, and later tumbled by 288527.61% in 2025.
  • Staar Surgical's Cash from Financing Activities (Quarter) stood at -$216000.0 in 2021, then soared by 193.52% to $202000.0 in 2022, then soared by 81.68% to $367000.0 in 2023, then plummeted by 129.97% to -$110000.0 in 2024, then soared by 993.64% to $983000.0 in 2025.
  • Its Cash from Financing Activities stands at $983000.0 for Q3 2025, versus -$4.5 million for Q2 2025 and -$948000.0 for Q1 2025.